Due to the significance of enhanced ROS and ROS-activated Ca2+ entry (through TRPM2 channel activation) for tumor cell apoptosis, the pro-oxidant action of CURC may enhance CISP efficacy for cancer management. Here, TRPM2 is linked to cancer.